Translational Development Acquisition Corp. (TDACU) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Translational Development...

    NASDAQ: TDACU · Real-Time Price · USD
    10.36
    0.00 (0.00%)
    At close: Aug 20, 2025, 3:59 PM

    Translational Development Acquisition Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
    Revenue
    		 1,065.8B n/a n/a
    Cost of Revenue
    		 320.87B n/a n/a
    Gross Profit
    		 744.92B n/a n/a
    Operating Income
    		 -196.36K -485.55K -70.66K
    Interest Income
    		 n/a n/a n/a
    Pretax Income
    		 -71.01K -485.55K -70.66K
    Net Income
    		 -71.01K -485.55K -70.66K
    Selling & General & Admin
    		 196.36K 485.55K 70.66K
    Research & Development
    		 n/a n/a n/a
    Other Expenses
    		 n/a n/a n/a
    Operating Expenses
    		 196.36K 485.55K 70.66K
    Interest Expense
    		 508.56B n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a
    Cost & Expenses
    		 -196.36K 485.55K 70.66K
    Income Tax Expense
    		 n/a n/a n/a
    Shares Outstanding (Basic)
    		 4.05M 4.05M 4.05M
    Shares Outstanding (Diluted)
    		 4.05M 4.05M 4.05M
    EPS (Basic)
    		 -0.02 -0.12 -0.02
    EPS (Diluted)
    		 -0.02 -0.12 -0.02
    EBITDA
    		 -71.01K -485.55K n/a
    EBIT
    		 -71.01K -485.55K -70.66K
    Depreciation & Amortization
    		 n/a n/a 70.66K

    Add to Watchlist